ADC Therapeutics

+$0.84 (+3.22%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ADCT and other ETFs, options, and stocks.

About ADCT

ADC Therapeutics SA is a clinical-stage biotechnology company. It engages in the research and development and commercialization of targeted antibody drug conjugates for patients with hematological malignancies and solid tumors.

CEO
Christopher John Martin
Employees
208
Headquarters
Epalinges, Vaud
Founded
2011

ADCT Key Statistics

Market Cap
2.09B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
107.21K
High Today
$26.95
Low Today
$25.85
Open Price
$25.87
Volume
137.45K
52 Week High
$38.34
52 Week Low
$20.01

ADCT Earnings

-$0.90
-$0.60
-$0.30
-$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 11, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure